Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Duncan

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Nature Reviews. Cancer|August 11, 2006
Polymer conjugates as anticancer nanomedicinesRuth Duncan
Current Opinion in Biotechnology|June 17, 2011
Polymer therapeutics as nanomedicines: new perspectivesRuth Duncan
Advanced Drug Delivery Reviews|August 25, 2009
Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learntRuth Duncan
Journal of Drug Targeting|November 10, 2006
Polymer conjugates for drug targeting. From inspired to inspiration!Ruth Duncan
Journal of Drug Targeting|August 9, 2017
Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first centuryRuth Duncan
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 31, 2014
2. Commentary on dendrimers: why dendrimers?: Original research article: Relationship between structure and biocompatibility in vitro preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers (2000)Ruth Duncan
Nature Reviews. Drug Discovery|May 17, 2003
The dawning era of polymer therapeuticsRuth Duncan
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2014
Polymer therapeutics: Top 10 selling pharmaceuticals - what next?Ruth Duncan
Current Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
Polymer-protein and polymer-drug conjugates in cancer therapyMaya Thanou, Ruth Duncan
Advanced Drug Delivery Reviews|November 22, 2005
Dendrimer biocompatibility and toxicityRuth Duncan, Lorella Izzo
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Nature Reviews. Cancer|August 11, 2006
Polymer conjugates as anticancer nanomedicinesRuth Duncan
Current Opinion in Biotechnology|June 17, 2011
Polymer therapeutics as nanomedicines: new perspectivesRuth Duncan
Advanced Drug Delivery Reviews|August 25, 2009
Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learntRuth Duncan
Journal of Drug Targeting|November 10, 2006
Polymer conjugates for drug targeting. From inspired to inspiration!Ruth Duncan
Journal of Drug Targeting|August 9, 2017
Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first centuryRuth Duncan
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 31, 2014
2. Commentary on dendrimers: why dendrimers?: Original research article: Relationship between structure and biocompatibility in vitro preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers (2000)Ruth Duncan
Nature Reviews. Drug Discovery|May 17, 2003
The dawning era of polymer therapeuticsRuth Duncan
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2014
Polymer therapeutics: Top 10 selling pharmaceuticals - what next?Ruth Duncan
Current Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
Polymer-protein and polymer-drug conjugates in cancer therapyMaya Thanou, Ruth Duncan
Advanced Drug Delivery Reviews|November 22, 2005
Dendrimer biocompatibility and toxicityRuth Duncan, Lorella Izzo
Pageof 7